8th International Human Genome Variation Meeting

描述（由申请人提供）：本申请申请美国国立卫生研究院资助，以部分资助美国学员参加将于2006年9月14-16日在香港数码港艾美酒店举行的第八届人类基因组变异和复杂基因组分析国际会议。这次会议召开得特别及时，因为人类基因组变异研究领域进展非常迅速，2005年10月完成了HapMap第一阶段项目，预计将在2006年夏天公布HapMap第二阶段的结果。此外，人们越来越认识到基因组的拷贝数多态性和结构变异是人类进化的重要标志和人类疾病的原因。我们将大量报道人类变异研究的新兴领域，并将不同领域的研究人员聚集在一起，促进合作，推动该领域进一步发展。这次会议的独特之处在于，它汇集了人类变异研究许多领域的顶尖研究人员，从将极大地改变该领域的新技术，到不同类型的人类变异产生的机制，到HapMap时代遗传研究的新统计方法，到基于比较基因组变异分析的分子进化研究，以及人类变异研究的社会和伦理意义。会议的目标是提出一个为期三天的计划，其中将包括基因组学，群体遗传学，分子进化，统计遗传学，分子流行病学和伦理学方面的国际知名专家的演讲。会议将致力于多样性和进化，基因组结构（包括结构多态性），群体遗传学，单倍型图谱的效用和分析，新的变异分析技术和策略，表型和疾病，人类基因组学中的伦理，法律和社会问题。

DESCRIPTION (provided by applicant): This proposal seeks NIH funding to partially support US trainees to attend the 8th International Meeting on Human Genome Variation and Complex Genome Analysis to be held at the Le Meridien Cyberport Hotel in Hong Kong from September 14-16, 2006. This meeting is particularly timely because the field of human genome variation research is moving very fast, with the completion of the HapMap Phase I Project in October 2005 and the anticipated publication of the HapMap Phase II results in the summer of 2006. In addition, there is increasing recognition that copy number polymorphisms and structural variations of the genome are important signatures of human evolution and causes of human diseases. We will devote substantial coverage of the emerging areas of human variation research and bring together investigators in diverse fields to promote collaborations and move the field even further along. The unique feature of this meeting is that it brings together top researchers in the many areas of human variation research, from radically new technologies that will change the field dramatically, to the mechanisms of how different types of human variations came about, to new statistical approaches for genetic studies in the HapMap era, to the study of molecular evolution based on comparative genome variation analysis, and to the social and ethical implications of human variation research. The objective of the meeting is to present a three day program, which will include presentations by internationally known experts in genomics, population genetics, molecular evolution, statistical genetics, molecular epidemiology, and ethics. Sessions will be devoted to diversity and evolution, genome structure (including structural polymorphisms), population genetics, utility and analysis of haplotype maps, new variation analysis technologies and strategies, phenotype and disease, ethical, legal and social issues in human genomics.